Shanghai Shen Lian Biomedical Corporation reported earnings results for the nine months ended September 30, 2023. For the nine months, the company reported sales was CNY 239.43 million compared to CNY 286.58 million a year ago. Revenue was CNY 239.43 million compared to CNY 286.58 million a year ago.

Net income was CNY 37.12 million compared to CNY 72.36 million a year ago. Basic earnings per share from continuing operations was CNY 0.09 compared to CNY 0.18 a year ago. Diluted earnings per share from continuing operations was CNY 0.09 compared to CNY 0.18 a year ago.